Trevi Therapeutics (TRVI) EPS (2019 - 2026)
Trevi Therapeutics (TRVI) EPS from Jun 30, 2019 to Mar 31, 2026. The TTM Trevi Therapeutics (TRVI) EPS is -$0.36. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Trevi Therapeutics (TRVI) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -36.85% |
| 3 Years TTM | -12.74% |
| 5 Years TTM | -27.09% |
| All Time TTM | -23.38% |
Annual EPS change of Trevi Therapeutics (TRVI)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.10 | -69.18% |
| 2025 | -$0.33 | -34.89% |
| 2024 | -$0.51 | +20.27% |
| 2023 | -$0.43 | -12.49% |
| 2022 | -$0.49 | -59.16% |
| 2021 | -$1.19 | -32.59% |
| 2020 | -$1.77 | +20.93% |
| 2019 | -$1.46 | N/A |
Comparison Trevi Therapeutics (TRVI) five years EPS CAGR with competitors
Trevi Therapeutics (TRVI) five years EPS CAGR is -27.09%.